<DOC>
	<DOCNO>NCT00482014</DOCNO>
	<brief_summary>The primary purpose study determine 2-year survival rate chemotherapy regimens patient inoperable non-small-cell lung cancer .</brief_summary>
	<brief_title>A Study Pemetrexed Plus Carboplatin , Pemetrexed Plus Cisplatin With Radiation Therapy Followed Pemetrexed Patients With Inoperable Non-Small-Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Inoperable non small cell lung cancer No weight loss great 10 % 3 month prior enrol trial Adequate kidney function Adequate liver function Adequate lung function Previous surgery remove lung tumor Previous chemotherapy radiation therapy lung cancer Inability take vitamin supplementation Heart attack within past 6 month Active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>